HEALTHTRONICS OSSATRON

Generator, Shock-wave, For Pain Relief

FDA Premarket Approval P990086 S003

This medical device record is a pma supplement. A supplement may have changed the device description/function or indication from that approved in the original pma. Be sure to look at the original pma record for more information.

Pre-market Approval Supplement Details

Approval for the healthtronics ossatron. The device is indicated for use for performing extracorporeal shock wave (esw) treatment in patients with chronic lateral epicondylitis (tennis elbow) that has failed to respond to conservative treatment. Chronic lateral epicondylitis is defined as lateral epicondylitis that has persisted for 6 months or more with a history of unsuccessful conservative treatment.

DeviceHEALTHTRONICS OSSATRON
Classification NameGenerator, Shock-wave, For Pain Relief
Generic NameGenerator, Shock-wave, For Pain Relief
ApplicantSANUWAVE, INC.
Date Received2001-11-05
Decision Date2003-03-14
Notice Date2003-05-01
PMAP990086
SupplementS003
Product CodeNBN
Docket Number03M-0173
Advisory CommitteePhysical Medicine
Supplement TypePanel Track
Supplement ReasonLabeling Change - Indications/instructions/shelf Life/tradename
Expedited ReviewNo
Combination Product No
Applicant Address SANUWAVE, INC. 11680 Great Oaks Way suite 350 alpharetta, GA 30022
Summary:Summary of Safety and Effectiveness
Labeling: Labeling Labeling Part 2
Approval Order: Approval Order

Supplemental Filings

Supplement NumberDateSupplement Type
P990086Original Filing
S004 2004-02-09 Normal 180 Day Track No User Fee
S003 2001-11-05 Panel Track
S002 2001-01-12 Real-time Process
S001 2000-10-19 Normal 180 Day Track

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.